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Abstract Methadone has a long and successful history in
the treatment of opioid addiction. In recent years, it has
become popular again—as potent and inexpensive analge-
sic in patients with chronic pain. Since methadone has been
used fatalities have been reported. In our study all
methadone-associated deaths in Zurich from 1998 to 2007
were analysed. Most of the 146 detected deaths of the past
10 years occurred during substitution programmes or illicit
intake of methadone while only three of them could be
attributed to methadone used as an analgesic. Noticeable in
our study was the high percentage of cases of combined
drug intoxication (76%). The most frequent co-intoxicants
were alcohol and cocaine. Mortalities attributed to metha-
done intoxication alone were a rare finding and could only
be detected in five cases of deceased who had received
methadone maintenance treatment. The aim of our study is
to assess the trends in the number and nature of methadone-
related fatalities in Zurich during the last 19 years. For this
purpose a previous study from Zurich (1989–1997) was
included, whereby a very long observation period and large
number of cases resulted.
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Introduction
The opioid methadone was initially synthesised by the
chemists Max Bockemühl and Gustav Erhart in 1939 and
first used as a highly potent analgesic [1]. Because of its
long half-life, good enteral resorption and low costs it
became an important substance in the treatment of opiate
addiction [1–4]. This measure successfully helped to reduce
mortality, criminal behaviour and the spreading of disease
transmitted through intravenous drug use [1, 5]. Other
studies showed a significant lower rate of additional
consumption of drugs—especially of opioids—and an
increase in quality of life [5, 6].
Methadone maintenance treatment (MMT) for heroin-
addicted persons started in the United States in 1964 and in
Europe (Uppsala, Sweden) in 1966. Maintenance pro-
grammes in Switzerland were made legal in 1975 and have
always been using only the racemic mixture (dl-metha-
done). Easy access to substitution programmes was imple-
mented in the canton of Zurich in 1991 [1, 7, 8].
Since initiation of the official statistics Swiss Health
Authorities have recorded approximately 18,000
methadone-treated addicts each year. Through the whole
period from 1999 to 2007 the number of persons enrolled in
a methadone programme in Zurich also remained stable
with about 3,900 individuals per year [9].
In recent years the usage of methadone as an analgesic
has become more important again and a correlation
between increased methadone distribution and a rise of
methadone-associated mortality is seen [10].
Since the substance has first been used, methadone-
related deaths have been reported. Several studies focussed
on forensic autopsies in which methadone was detected in
postmortem toxicology and tried to point out its role in
drug-associated deaths [1–23].
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In the catchment area of the Institute of Legal Medicine of
Zurich a large drug scene is located and one third of all drug
deaths of Switzerland are undergoing forensic examination
here. With our research we wanted to evaluate the changes in
Zurich during the past 19 years, and also the proportion of
death due to methadone as an analgesic. Is there still a
progressive increase in death cases related to methadone?
Methods
All autopsies during a 10-year-period (n=4,121), from
1998 to 2007, were retrospectively evaluated. Searching the
keyword methadone in our archive revealed 159 cases.
In all of the 146 included methadone-related fatalities
without severe decomposition a complete autopsy had been
carried out and detailed documentation was available from
which demographic data and the cause and manner of death
could be extracted.
Results of chemical-toxicological testings were mainly
based on blood and urine samples. Only in a few cases
toxicologic analysis were performed in organs and tissues
(kidney and muscle). As part of routine toxicologic analysis
urine drug screens were performed by immunoassay testing for
EDDP (2-ethylidene-1.5-dimethyl-3.3-diphenylpyrrolidine;
CEDIA®-test), opioids, benzoylecgonine, cannabinoids,
amphetamines, benzodiazepines and barbiturates. Whenever
possible blood from the femoral vein was preferred and tested
after extraction with solid phase extraction by gas chromatog-
raphy–mass spectrometry (GC-MS), quantifying methadone
and illicit drugs. Alcohol analyses had been carried out with
GC-FID (headspace). In cases with appropriate history,
psychotropic agents—such as antidepressants—were also
included in the screening. Analysis of hair samples had not
been performed by default.
Unfortunately only few of our records contained full
information pertaining history of drug consumption, especial-
ly of methadone intake, duration of a current maintenance
programme, daily methadone dosage and circumstances of
death. For this reason it was not possible to appraise the
phenomenon of drug tolerance. The manner of death therefore
could not often be clearly classified as a suicidal or accidental
drug overdose.
In a further step we compared our data with the data of a
previous study (1989–1997) raised by colleagues of our
Institute.
Results
A total of 146 cases (3.5% of all performed autopsies)
showed positive results for methadone in the postmortem
toxicologic analysis. Figure 1 shows the development of
drug-related deaths during the investigated time period. A
progressive increase until 2006 and a sudden drop in 2007
are obvious. Table 1 provides an overview of the whole
data. The individuals were predominantly male (n=102,
70%) and ranged from 17 to 59 years (mean age 36 years).
The females ranged between 17 and 61 years (mean age
37 years). Methadone blood levels (MBL) ranged from 70
to 14,000 µg/L (mean 1,324 µg/L, median 700 µg/L).
Fifty-seven deceased (39%, mean age 37 years) had been
enrolled in MMT (42 men and 15 women) and had received
a methadone dosage between 20 and 300 mg day−1. MBL
ranged from 100 to 12,000 µg/L (mean 1,574 µg/L, median
900 µg/L).
The group of 86 individuals without MMT (59%, mean
age 35 years) included 60 males and 26 females with a
daily consumption of methadone of 15–300 mg. MBL
ranged from 70 to 9,000 µg/L (mean 1,022 µg/L, median
615 µg/L).
Three women (2%, 37, 43 and 53 years) had received
methadone as an analgesic. MBL of 430, 1,200 and
14,000 µg/L were found.
Mortalities (7.5%; n=11, mean age 39 years) were
attributed to methadone intoxication alone (MBL, 500 to
2,500 µg/L, mean 1073 µg/L, median 850 µg/L). Five of
these 11 patients (45%)—all females—died while receiving
MMT (MBL, 650–1.700 µg/L; mean 1,040 µg/L, median
850 µg/L). The group of the six remaining individuals who
were not participating in MMT (MBL, 500 to 2,500 µg/L;
mean 1,100 µg/L, median 780 µg/L) was predominated by
males.
Combined drug intoxication was identified in 111 of 146
individuals (76%, mean age 35) and included 81 men
(mean age 35 years) and 30 women (mean age 36 years).
MBL ranged from 70 to 14,000 µg/L (mean 1,492 µg/L,
median 700 µg/L). The combination of methadone and one
other substance (n=49) was dominated by alcohol. The
group with the combination of methadone and only
benzodiazepines was dominated by females—all other
groups of combined drug toxicity were predominated by
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Fig. 1 Methadone maintenance treatment (MMT) and methadone-
related deaths in Switzerland and Zurich. a Persons in MMT in
Switzerland (×1,000). b Persons in MMT in Zurich (×100). c
Methadone-related deaths in Zurich
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males. The combination of three to six substances was
found in 62 cases.
Just four of these 111 cases of combined drug intoxica-
tion could definitely be classified as a suicidal incident. In
all of the remaining 107 individuals no further assessment
could be made whether a suicidal or accidental intoxication
was present.
Alcohol—at the top of the list of all detected co-
intoxicants—was present in 58 of all 146 cases (40%).
Blood alcohol concentration levels ranged between 0.02
and 4.07 g/L (mean 0.76 g/L, median 0.32 g/L).
Cocaine or its metabolites were detected in 55 of the 146
cases (38%) ranging from 5 to 190 µg/L for cocaine (mean
45 µg/L, median 25 µg/L), from 6 to 1,500 µg/L for
benzoylecgonine (mean 50 µg/L, median 110 µg/L) and from
10 to 6,000 µg/L for methylecgonine (median 1,068 µg/L,
median 535 µg/L). In four cases, ethylecgonine was found as a
marker for combined use of alcohol and cocaine. Eighteen of
these 55 deceased (32%) had been in a current MMT.
Benozodiazepines were found in 41 of 146 samples
(28%), among them the most frequent were nordazepam,
oxazepam and diazepam. In 37% (n=15) the intake was
related to participation to MMT.
Other opioids were seen in 37 of the 146 cases (25%)—
morphine 5 to 5,000 µg/L (mean 517 µg/L, median 50 µg/
L), codiene 3 to 700 µg/L (mean 62 µg/L, median 15 µg/L)
and monoacetylmorphine (six cases) 5 to 40 µg/L (mean
17 µg/L, median 25 µg/L). Fourteen of these 37 persons
(38%) were enrolled in MMT. Psychotropic agents—
mainly antidepressants—were detected in 24 of 146
samples (16%).
Amphetamines (1%) and cannabinoids (1%) could not
be detected as single intoxicants in combination with
methadone and played a minor role in patients with a
combination of three or more substances.
In 11 of the 146 cases (7.5%) methadone could be
detected but death was attributed to natural causes including
cardiovascular disease (n=4), hypovolemic shock (n=3),
pneumonia (n=2), insufficiency of the liver (n=1) and
acute pancreatitis (n=1). In these cases MBL ranged from
120 to 1,200 µg/L (mean 529 µg/L, median 430 µg/L).
In the five cases (3.4%) of non-natural death that could
not be attributed to the consumption of substances, we
found two cases of failure of central regulation after blunt
trauma and one case each of drowning, hypothermia and
polytrauma (MBL, 170–2,500 µg/L; mean 1744 µg/L,
median 250 µg/L).
In eight of the 146 cases (5.5%) the cause of death
remained unexplained despite extensive forensic examina-
tion. MBL ranged from 330 to 900 µg/L (mean 653 µg/L,
median 620 µg/L).
Discussion
Several studies have discussed the role of drug-related
deaths involving methadone. We observed an increase in
the number of methadone-related deaths in recent years
which is consistent with the findings of many other
investigators [1, 4, 6, 13, 16]. One author however found
a decrease [3]—but this finding may result from only a
small collective.
The total number of cases found during the investigated
time periods varies a lot. These differences may be explained
by the study’s design, regional, social and cultural factors or
simply the availability of drugs or maintenance programmes.
Among the long-term studies [13–15, 17] with an
observation period of 10 years or more with 146 deceased,
we investigated a relatively large number of cases.
However, some shorter studies of 5 years in length or less
Zurich [1989–1997) Zurich [1998–2007]
Cases [n] 114 146
Males [%] 61 70
Females [%] 39 30
Mean age [years] 29 36
MBL-range [µg/L] 30–4,500 70–14,000
Mean MBL [µg/L] 730 1,324
Median MBL [µg/L] 500 700
MMT [%] 39 39
Methadone as analgesic [%] 0 2
Methadone mono-intoxication [%] 10.5 7.5
Combined intoxication [%] 64 76
Natural death [%] 9.7 7.5
Non-natural death (except intoxication) [%] 15.8 3.4
Unclear death [%] 0 5.5
Table 1 Changes in methadone-
related deaths in Zurich from
1989 to 2007
MBL methadone blood level,
MMT methadone maintenance
treatment
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presented data with an even larger number of victims [1,
12]. The study by Hauri et al. [15] (Table 1) reviewed 114
methadone-associated deaths between 1989 and 1997.
Compared to his data our study revealed an increase of
28% of methadone-associated deaths in Zurich in the last
10 years, while the number of drug addicts in MMT in
Zurich and Switzerland remained stable [9]. We could not
find a conclusion for the sudden drop in the number of
fatalities in Zurich in 2007. An increase in the proportion of
men and mean age was also seen in our collective. Other
significant differences to Hauri were a tripling of the
highest MBL and a doubling of the mean MBL in our study
while the median MBL did not differ that much (500 µg/L
vs. 700 µg/L). By substantial changes in methodology from
gas chromatography–nitrogen phosphorus detector to GC-
MS in Zurich between 1989 and 2007 the sensitivity of
detection increased, but the quantitative results for the
therapeutical levels remained comparable. The number of
persons in MMT did not change over the years. New
findings were fatalities associated with methadone used as
an analgesic—an observation which had also been dis-
cussed by health authorities in the last time [10]. According
to our evaluation the total number of cases which could be
assigned to methadone intoxication alone, natural death and
non-natural death (except lethal intoxication) decreased. In
Hauri’s collective, 64% of deaths could be attributed to
combined drug intoxication. We found a distinct increase
up to 76%. Between 1989 and 1997 in Zurich the most
frequent additional substances used with methadone were
benzodiazepines, alcohol and other opioids. The main co-
intoxicants in our blood samples were alcohol and cocaine
while the influence of benzodiazepines and other opioids
appeared to regress.
We showed a distinct and even increasing predominance of
males among methadone-related deaths which is also a
common finding in other studies [3–6, 9]. The only exception
is the study by Worm [23]. However she presented just a
small number of cases where the data cannot be accepted as
representative of all cases.
The mean age in other investigations, including the
studies from Zurich, ranged from the late 1920s to the late
1930s [1, 3, 4, 6, 8, 23]. Our recent study, however, showed
the mean age increase by 7 years. This supports findings
that mortality is reduced as a consequence of MMT [1].
Of note in our study were blood concentrations of
methadone with values up to 14,000 µg/L. Compared to the
results of other authors this is more than a tripling [1, 6, 8,
15]. The existence of such high MBL implies a methadone-
induced tolerance and enough survival time for resorption
in case of oral application or an intravenous application of a
large dosage of methadone [21]. With regard to the
increasing age of the deceased in our study, an induction
of tolerance is quite comprehensible and would also lead to
an intake of a higher daily methadone dosage. The
comparability of the data from Zurich is ensured by the
use of the racemic mixture from the start of MMT in
Switzerland—a fact that was not traceable in other studies
and which may have a severe influence in the direct
comparison of detected MBL. In our study, only eight of
146 cases showed a MBL over 4,500 µg/L. This explains
the high mean MBL of 1,324 µg/L and the “usual” median
MBL of 700 µg/L. However, many previous investigators
have also commented on the difficulty in performing
postmortem toxicologic analyses, interpreting the results
and establishing a lethal MBL [1, 4, 6, 11, 14, 19, 21].
Therefore a large degree of error is possible.
The ratio of persons in Zurich with and without MMT
has not changed in the last 20 years. Compared to other
studies our detected rate of deceased receiving treatment
(39%) is in the lower range. Accordingly 61% of the
victims in our collective must have received their metha-
done illegally and without medical support. The apparently
low acceptance of MMT in the canton of Zurich cannot be
understood by the authors because to the easy access to
substitution programmes in that area.
Many previous studies have emphasised the frequent
presence of other drugs in methadone-related deaths. In our
study, 76% of the deceased died as a result of combined
drug intoxication. A similar or even higher percentage of
combined toxicity was seen in other studies [1, 3, 4, 6, 14,
15, 22]; however not all of them are representative—some
sampled only a very small number of cases. The develop-
ment in Zurich from 1989 to 2007 documents the rising
problem of parallel consumption of several substances and
an increased importance of alcohol, while the consumption
of benzodiazepines and other opioids decreased—a finding
consistent only in the study by Graß [14]. In contrast most
of the previous studies, revealed benzodiazepines as the
most frequent additional substances [3, 4, 15, 22, 23].
According to the development in Zurich’s and Switzer-
land’s drug scene in recent years [20], we detected cocaine
in second place which seemed to be of no particular
relevance in other studies.
In Dobler-Mikola’s study [7], a more frequent use of
illicit drugs during MMT in Switzerland was seen and
explained by a presumably higher activity of the drug
scene. On the other hand, it is possible that due to a higher
sensitivity of the toxicological analyses more additional
substances were detected.
As aforementioned in many cases it was not possible to
classify the manner of death as a suicidal or accidental drug
overdose due to a lack of information. Only four of our 111
deceased (3.6%) had verifiably committed suicide with the
intake of several substances while other studies showed a ratio
of suicides close to 50% [16]. Hauri et al. [15] identified 12
cases (10.5%) of suicide in Zurich between 1989 and 1997.
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In the last few years several case reports and studies
have described the occurrence of cardiac arrhythmia with
the use of methadone particularly with regard to prolonga-
tion of the QT-interval [2, 18]. To determine the cause of
death clearly as fatal arrhythmia it would be necessary to
have very detailed information about the deceased—general
medical anamnesis and extensive data of the current MMT.
Finally, MMT, if carried out correctly, is a very useful
and save tool in the treatment of heroin addiction. Only five
deaths in our 10-year-study were attributed to methadone
intoxication alone while receiving MMT. Compared to an
average of 3,900 substituted persons in the canton of Zurich
each year this is a very rare finding (0.1%). Furthermore the
mean age in the deceased in our collective increased by an
average of 7 years (in the group of MMT by 8 years),
which is presumably another positive effect of methadone,
especially in MMT. In most of our cases combined drug
intoxication was present in terms of parallel consumption of
other substances which should not occur according to the
guidelines of MMT. Thus, a stricter control of the
participants in maintenance treatment and additional sup-
port in cases of concomitant drug use should be considered
in the future.
Our study pointed out the general problem of interpre-
tation of postmortem MBL and the retrospective collection
of reliable data. Therefore a prospective study in close
collaboration with an institution for substitution treatment is
pursued, with special regard to pain treatment and cardiac
side effects of methadone.
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